FDA 483 - MIRA, Inc. - March 07, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of MIRA, Inc. in Uxbridge, MA, a manufacturer of Class II medical devices, revealed two significant observations. The firm failed to adequately establish process control procedures, leading to the use of expired materials in device assembly, which was a repeat observation. Additionally, procedures for ensuring purchased products and services conform to specified requirements were not adequately established, with critical suppliers not being evaluated as per the firm's own procedures.
- Person
ID · 933d220f-769f-44ee-a5e3-ded68f2822c2